Volitionrx (VNRX) Net Margin (2019 - 2025)
Volitionrx (VNRX) has disclosed Net Margin for 9 consecutive years, with 1206.14% as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Net Margin rose 2068.0% year-over-year to 1206.14%, compared with a TTM value of 1481.73% through Sep 2025, up 84150.0%, and an annual FY2024 reading of 2186.27%, up 236926.0% over the prior year.
- Net Margin was 1206.14% for Q3 2025 at Volitionrx, down from 12.25% in the prior quarter.
- Across five years, Net Margin topped out at 513.26% in Q4 2021 and bottomed at 5860.53% in Q1 2023.
- Average Net Margin over 5 years is 1668.85%, with a median of 1206.14% recorded in 2025.
- The sharpest move saw Net Margin soared 106615916bps in 2021, then crashed -593406bps in 2023.
- Year by year, Net Margin stood at 513.26% in 2021, then plummeted by -85bps to 78.6% in 2022, then plummeted by -4636bps to 3565.25% in 2023, then increased by 15bps to 3022.78% in 2024, then soared by 60bps to 1206.14% in 2025.
- Business Quant data shows Net Margin for VNRX at 1206.14% in Q3 2025, 12.25% in Q2 2025, and 2241.03% in Q1 2025.